PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0010068|coronary disease |
| Sentences | 5 |
| PubMedID- 20674994 | Likelihood of obstructive coronary disease in metabolic syndrome patients with abnormal stress echocardiography. |
| PubMedID- 21196002 | [prevalence of metabolic syndrome in patients with stable coronary disease: therapeutic objectives and utilization of cardiovascular drugs]. |
| PubMedID- 20209376 | Highly sensitive c-reactive protein and male gender are independently related to the severity of coronary disease in patients with metabolic syndrome and an acute coronary event. |
| PubMedID- 21977022 | Although the individual components of metabolic syndrome are clearly associated with increased coronary disease, there are also reports demonstrating that diabetes patients without metabolic syndrome have no greater prevalence of coronary artery disease [28, 29], indicating less importance of isolated hyperglycemia in macrovascular complications. |
| PubMedID- 25971444 | North america, europe, and australiathe effect of rimonabant on regression of coronary disease in patients with the metabolic syndrome and cad2008335/341cad,obesity87.6/86.3−4.7/-3.6rim 20 mg vs placebo on bases of statins therapy18rim can reduce progression of coronary plaque, and increase hdl-c levels, decrease triglyceride levels.hiro t20; japan-acsrct: prospective, randomized, open-label, parallel group, multicenter. |
Page: 1